After remaining under pressure since July 2025, the stock has staged a strong turnaround in April, rebounding 41.2%. (Pixabay)AI Quick ReadAayush Wellness shares jumped 9% in Thursday’s trade, 24 April, hitting a three-month high of ₹39 apiece. The stock defied the broader market sell-off and extended gains for the second consecutive session, taking its two-day cumulative rise to 21%.
While there were no major fundamental triggers, technical factors supported the stock at higher levels. Around one million shares were traded on both the BSE and NSE by the end of the session.
In a continued effort to expand its preventive healthcare portfolio, the company announced the launch of a new product.
According to the company, the advanced herbal formulation is designed to naturally detoxify, protect, and regenerate liver cells, addressing growing liver health concerns driven by modern lifestyle habits, environmental toxins, and poor dietary choices.
“The launch strengthens Aayush Wellness Limited’s expanding preventive healthcare portfolio and positions the company to tap into a large and growing wellness opportunity driven by lifestyle disorders, rising health awareness, and increasing consumer preference for daily condition-support products,” the company said in its filing.
The company has recently expanded its product portfolio across Herbal Masala, Beauty Gummies, Sleep Gummies, Lung Care Tablets, and now Liver Care Tablets, demonstrating a scalable platform approach to consumer healthcare innovation.
India’s nutraceutical market, currently estimated at around $18 billion, is witnessing strong double-digit growth, supported by rising health awareness, increasing disposable incomes, and a shift toward preventive healthcare.
In this context, Aayush Wellness is strategically positioning itself to capture emerging opportunities by expanding its product range and strengthening its presence in high-growth wellness categories.
Commenting on the launch, Naveenakumar, Managing Director of Aayush Wellness Limited, said, “Liver health remains an under-addressed yet critical component of overall well-being. With our Liver Care Tablets, we aim to offer a preventive solution that empowers individuals to proactively manage their health.
“By integrating Ayurvedic wisdom with clinically validated ingredients, we are building solutions that are both effective and aligned with evolving consumer preferences,” he added.
After remaining under pressure since July 2025, the stock has staged a strong turnaround in April, rebounding 41.2% and offering much-needed relief to shareholders who had been awaiting a recovery for nearly a year.
The shares came under severe selling pressure after hitting a peak of ₹267 in July, entering a prolonged correction and falling to as low as ₹26 in recent months. The decline followed a stellar rally between November 2023 and June 2025, during which the stock surged from ₹2.13 to ₹203, delivering a massive gain of around 9,500%.
On a yearly basis, the stock delivered an exceptional return of 3,219% in CY24 alone, marking its strongest annual performance since listing. Cumulatively, the stock is up nearly 3,000% over the past three years and around 2,000% over the last five years.
Disclaimer: We advise investors to check with certified experts before making any investment decisions.
Ksheera Sagar has been working as a Market Research Analyst at LiveMint for the past four years, covering stocks, commodities, and broader financial markets. In this role, he closely tracks daily market movements, corporate earnings, sector trends, and macroeconomic developments.
He has over a decade of experience in the financial services industry and has previously worked with multiple organisations, including global investment bank J.P. Morgan, bringing strong research experience into the newsroom.
During his career, he has gained extensive exposure to equity research, market analysis, and financial data interpretation, strengthening his expertise across asset classes and market cycles.
He is known for his data-driven analysis and crisp, listicle-style market stories that break down complex financial developments across key markets for a wide audience. His strong research skills enable him to write detailed and insightful stories on stocks and sectors, focusing on the underlying factors driving market movements.
His work combines quantitative insights with clear storytelling, presenting financial developments in a clear and structured manner. Moreover, he enjoys writing multibagger and listicle-style copies. Outside of work, Ksheera enjoys playing the piano and exploring new places. He has a keen interest in travel, music, and continuously learning about global markets and economic trends.